PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Obstetrics and Gynecology0 citations

Pneumococcal Vaccination Series Completion Among Eligible Pregnant Individuals ID 3390

View Full Paper
MMMaria Cristina MarcosEHElizabeth HabashKDKarley Dutra

Key Points

  • This study aims to assess pneumococcal vaccination rates among pregnant individuals.
  • Conducted a retrospective observational cohort study of 492 eligible pregnant individuals.
  • Collected demographic data and vaccination history from participants who delivered at the institution in 2024.
  • Utilized bivariate analysis to compare vaccination during pregnancy versus not.
  • Performed Logistic regression analysis to identify factors associated with up-to-date vaccination.
  • Only 1% of participants received pneumococcal vaccination during pregnancy.
  • 54% of participants were Black, 24% White, and 13% Hispanic.
  • Preexisting diabetes linked to three times higher odds of being up to date with vaccination.

Abstract

INTRODUCTION: Streptococcus pneumoniae is a leading cause of pneumonia, meningitis, and invasive disease, with certain conditions causing a higher risk of disease. The American College of Obstetricians 95% CI, 1.208–6.329). CONCLUSIONS/IMPLICATIONS: This is the first study to evaluate pneumococcal vaccination during pregnancy. Pneumococcal vaccination rates during pregnancy were low at only 1%. Increasing provider awareness and vaccine access may help raise rates among eligible pregnant individuals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Marcos et al. (2026) studied this question.

synapsesocial.com/papers/69faa25e04f884e66b533098https://doi.org/10.1097/aog.0000000000006268.03
Ask AI
Helpful
Bookmark
Share
View Full Paper